CT26 and MC38 are two immunogenic14, 15 colon tumour models that demonstrate PD-L1 expression on tumour cells as well as tumour infiltrating immune cells in vivo (Fig. 1c), with increased tumour PD-L1 expression following IFNγ exposure (Supplementary Fig. 1). This evidence concerns the gene IFNG and neoplasm.